Ultragenyx Pharmaceutical Inc. 4
4 · Ultragenyx Pharmaceutical Inc. · Filed Jul 17, 2014
Insider Transaction Report
Form 4
Nadav Eran
Director
Transactions
- Award
Stock Option (Right to Buy)
2014-07-10+7,500→ 7,500 totalExercise: $40.37Exp: 2024-07-09→ Common Stock (7,500 underlying)
Footnotes (1)
- [F1]The option shall vest in full on the earlier of (i) the issuer's next Annual Meeting of Stockholders and (ii) July 10, 2015.